NOACS Seminar in May 2022, Seminar Guidelines and global implementation strategies June 2022
May, 9th – 13th 2022, NOACs
Non-Vitamin K-dependent oral anticoagulants (NOACs) exert their effect by directly inhibiting thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban, edoxaban) which facilitate the final steps of coagulation. These agents have been developed as alternatives to Vitamin K antagonists (VKAs) for the prevention and treatment of thromboembolism with increased efficacy and/or safety for some indications. Reduced bleeding bleeding complications and coagulation testing under NOAC therapy may enhance patient compliance.
To stimulate a high degree of interaction and to give faculty and participants a chance to exchange experiences and ideas and to benefit from a optimized time management in terms of travel we have chosen a new locationin Burgenland/ Austria.
Here we will all stay during the meeting, work together in the lecture hall and hands-on workshops and will have all meals together. The essence of the seminar is to provide up-to-date education about the pathophysiology of bleeding in different clinical settings, methods of laboratory monitoring, as well as treatment options, treatment algorithms and international guidelines. The academic faculty will consist of experts, who are well recognized in the scientific and medical world.
June, 20th - 24th 2022, Guidelines and global implementation strategies
Severe perioperative bleeding is a challenge for the doctors and might become a drama for the patient.
Besides good team work a good knowledge about the physiology and pathophysiology of coagulation, diagnostic possibilities and therapeutic strategies are essential to succeed. In the recent years new insights of coagulation changed our understanding. The concept of the waterfall cascade is skipped and replaced by the cellular model of coagulation. Newer diagnostic tools facilitate monitoring of coagulation at the bedside of the patient. The bundle of procoagulant therapeutic options and saving the patient’s own blood are enlarged. Treatment algorithms assist in individualized decision making. Pre- and postoperative interventions improve the patients’ tolerance to anaemia and bleeding. Overall, perioperative bleeding management gets more personalized to the actual needs.
In the light of this development we want to share knowledge and experiences on coagulation and anaemia management and want to discuss different approaches and challenges with laboratory specialists, hematologists, internists and anesthesiologists. Evidence-based guidance in the recommendations from the ESAIC – 2nd update 2022 – will be presented and tricks for implementation will be discussed.
To meet this goal and in collaboration with the Danube University Krems, University for Continuing Education, we are organizing an educational from Sunday 19th (Arrival) to Thursday 23th June 2022.
To stimulate a high degree of interaction and to give faculty and participants a chance to exchange experiences and ideas we chose a special location in Burgenland/Austria. Here participants will all stay during the meeting, work together in the lecture hall and will have all meals together. In that way we want to make sure that the exchange and discussion is extended from the lecture hall.
The academic faculty will consist of experts, who are well recognized in the scientific and medical world. Another essence of the seminar is to record state-of-the-art lectures presented by co-authors of the ESAIC guidelines updates and to disseminate information as e-learning modules.
For a selected group of 25 invited participants, who have undergone an application/evaluation process and have agreed to contribute to the meeting by presenting a case report from their work environment and to provide their input to the discussions and interactive lectures, travel costs (Economy Class Airfare, train), accommodation and course materials will be covered by the organizers, who were able to recruit unresctricted funds for this unique educational activity.
Based on the concept of “train the trainers”, educational materials will be provided to participants in order to transfer professional competence to other practitioners in their countries. Furthermore, hands-on workshops on point-of-care coagulation analyzers will enable participants to gain the skills required for physiology-driven point-of-care-guided bleeding management. Discussions and case presentations from our international participants will encourage exchange of clinical experiences during this one week intensive seminar.
Another main focus of the meeting is to trigger global networking that might lead to international registries or collaborations in future randomized controlled trials.
We are looking forward to receiving your application for this special seminar series!
Prim. Univ.-Prof. Dr. Sibylle Kietaibl, MBA